e.l.f. Beauty Inc. stocks have been trading up by 8.15 percent following strong earnings and robust growth outlook.
Click Here for a Millionaire's POV on Trading ELF
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- ELF delivered FY26 net sales growth of 25% (Q4 +35%) and a seventh straight year of share gains, though heavy spending, tariffs, and a non-cash earn-out drove a Q4 GAAP loss.
- The acquired rhode brand produced about $390M in annualized FY26 net sales, growing roughly 80% year over year and expanding into Mexico plus seven more European markets with a new Summer ’26 collection.
- Naturium rolled out its “Glow Better Together” campaign around its Glow Getter body line, leaning on creator Bretman Rock to keep momentum as one of the fastest-growing U.S. skincare names.
- Major Wall Street firms cut ELF price targets but kept Strong Buy, Buy, or Overweight ratings, highlighting strong demand, international growth, and rhode’s strength despite softer trends in the core line.
- ELF beat Q4 EPS and revenue expectations with $449.3M in sales versus $423.1M consensus, helping the stock pop about 4% to $52.60 after results and guidance.
Live Update At 10:03:03 EDT: On Monday, June 08, 2026 e.l.f. Beauty Inc. stock [NYSE: ELF] is trending up by 8.15%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
ELF has been trading like a high-beta growth rollercoaster, but the trend has bent back up. Over the past few weeks, ELF shares have bounced from the low $50s to close near $53.59 on 2026/06/08, reclaiming ground after a volatile post-earnings reset.
The daily chart shows a sharp spike around the Q4 print, with ELF jumping from roughly $51 to near $57 in late May before pulling back and then grinding higher again. That pattern tells traders the first wave of earnings enthusiasm cooled, but dip buyers stepped in as the growth narrative held.
Intraday, the latest session shows classic accumulation. ELF opened weak at $50.05, briefly flushed to $49.22, then ripped steadily to intraday highs around $53.70, finishing near the top of the range. That kind of open-low/close-high action often signals shorts covering and momentum traders pressing long.
Fundamentally, ELF is a classic “high growth, high expectations” name. Revenue over the last year sits around $1.64B, with three- and five-year growth rates above 40% annually. Margins are mixed: a rich 70.7% gross margin but only 4.6% EBIT margin and a slim 1.61% net margin as the company leans into SG&A, tariffs, and acquisition costs.
More Breaking News
- SPCE Stock Whipsaws As 2026 Flight Plans Face Heavy Cash Burn
- LASE Stock Rockets As Defense And Medical Deals Ignite Momentum
- NEXR Stock Rockets As Momentum Traders Pile In
- BCDA Surges As BioCardia Wins Key FDA Trial Breakthrough
Valuation is still premium, with a P/E near 139 and price-to-sales about 2.3. For traders, that means the stock will react hard to any change in growth or margin momentum—both up and down.
Why Traders Are Watching ELF Right Now
ELF is back on momentum screens because the story is evolving from single-brand cosmetics to a broader global skincare platform. The key catalyst is rhode. ELF paid about $1B for the brand, and now the numbers are starting to justify that bet. Rhode generated roughly $390M in annualized net sales in fiscal 2026, growing about 80% year over year and ranking as the number-one U.S. skincare brand by earned media value.
Now rhode is stepping into Mexico—its first Latin American market—and seven more European countries, backed by a Summer ’26 bronzed, glow-focused collection. For traders, that means fresh geographic catalysts and product news flow that can spark multi-day moves in ELF whenever early demand data or sell-through chatter hits.
Naturium is the second engine. ELF’s Naturium unit just launched its “Glow Better Together” campaign built around the Glow Getter body-care line and creator Bretman Rock. That keeps Naturium in the social-media slipstream and helps cement it as one of the fastest-growing U.S. skincare brands. The more Naturium and rhode scale, the less ELF depends on its slowing core cosmetics line.
At the corporate level, Q4 was a statement quarter. ELF posted $449.3M in revenue, crushing the $423.1M consensus and beating on adjusted EPS as well. It was the seventh straight year of net sales and share gains, and traders rewarded that with a roughly 4% move to $52.60 after the print and guidance.
Yes, the quarter also came with a GAAP net loss, pressured by heavy SG&A, higher tariffs, and a big non-cash earn-out revaluation. That’s why Wall Street has trimmed price targets. Raymond James, UBS, JPMorgan, Canaccord, BofA, and B. Riley all cut their ELF targets, some quite sharply. But they all kept Strong Buy, Buy, or Overweight ratings, framing this as a valuation and expectations reset—not a broken growth story.
FY27 guidance for 12–14% revenue growth and modest EPS expansion is more conservative than the market wanted, yet still healthy. For traders, that sets up a classic “prove-it” phase: if ELF keeps beating those tempered numbers, you get fuel for the next leg up.
Conclusion
ELF now trades at the intersection of big growth and big scrutiny. On one hand, you have 25% FY26 net sales growth, Q4 revenue up 35%, a seventh year of share gains, and adjusted EBITDA up 13% with a 20% margin. On the other hand, you have a GAAP loss, rising leverage after the rhode deal, tariff pressure, and a core cosmetics segment that several analysts say is slowing while skin care does the heavy lifting.
Around that, ELF is running an aggressive brand playbook. The flagship e.l.f. Cosmetics brand is leaning into culture-driving partnerships like SURVIVOR 50 and the limited e.l.f. x SURVIVOR Buff Bundle. The empowering.legendary.females. platform is amplified by sponsoring Katherine Legge’s historic Indy 500/Coca-Cola 600 “Double,” which deepens ELF’s inclusive, edgy identity. These campaigns don’t move today’s EPS, but they build a moat in a crowded beauty aisle.
Traders should respect both sides of this tape. High growth plus high expectations equals high volatility. That’s where tight risk management comes in. As Tim Sykes loves to remind traders, “The market doesn’t care about your opinion, only your discipline. Patterns pay those who prepare and punish those who hope.” As Tim Bohen, lead trainer with StocksToTrade says, “The best way to learn is by tracking trades, wins, losses, and lessons learned. Every trade has something to teach.” Together, those ideas underscore that discipline isn’t just about managing a single trade in ELF, but about building a repeatable trading process over time.
ELF offers plenty of patterns right now—earnings gaps, pullbacks, and breakout attempts—all backed by real fundamental momentum from rhode, Naturium, and global expansion. Use this information for education and research, stick to your rules, and let the price action confirm the story before you act.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

